Promising novel therapies for the treatment of endometrial cancer
about
Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cellsRapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatment.MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo.Terpenoids from Zingiber officinale (Ginger) induce apoptosis in endometrial cancer cells through the activation of p53Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial Cancer.Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processingPoly(ADP-ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic.Aromatase inhibition: a potential target for the management of recurrent or metastatic endometrial cancer by letrozole: more questions than answers?The role of the SDF-1/ CXCR7 axis on the growth and invasion ability of endometrial cancer cells.MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins.Synthesis, cytotoxic properties and tubulin polymerization inhibitory activity of novel 2-pyrazoline derivatives.Generation and characterization of orthotopic murine models for endometrial cancer.LAPTM4B gene polymorphism and endometrial carcinoma risk and prognosis.MicroRNA-365 targets multiple oncogenes to inhibit proliferation, invasion, and self-renewal of aggressive endometrial cancer cells
P2860
Q27851999-30F3D0E8-52AC-480D-9C88-E0E86347E650Q28477353-46B62E30-B97B-4277-BFEE-8862F4253DE5Q33903478-F0437983-0B96-4DFA-9977-A887175E3FB5Q34039589-688E5210-EEA2-4C25-B469-EFD26B0F4402Q34541738-DFE0C509-A301-4923-95B2-0ED897B3EACBQ35084900-5AFFF278-ADDA-4835-AEB2-F809E295B497Q36471479-62ED8AAA-36AE-4247-A5B1-D6CD5F964124Q36689074-9F7D120D-2B85-430E-B0B8-B283D319141BQ37826009-F5C66762-2252-4C77-9EE1-C81BE64D47CFQ37854068-F20488D9-2BFD-4FD5-83F2-ABAE3B5119A5Q38714746-173DA9CC-17C4-4E34-B920-CB8D741F9160Q38926686-FC5854AE-BE21-470D-A46F-23377C5C9E3EQ39347168-BB38E2DC-FB4A-40DC-B87A-C40F10A91F76Q39422372-3B3CA1A3-8E20-4AD1-9C3B-4358D87681FCQ45121136-5DA1EECB-FF5F-4552-A58B-4920C6C349DCQ59135253-4B0FD23C-52A0-4779-9567-1709B70D14DF
P2860
Promising novel therapies for the treatment of endometrial cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Promising novel therapies for the treatment of endometrial cancer
@ast
Promising novel therapies for the treatment of endometrial cancer
@en
type
label
Promising novel therapies for the treatment of endometrial cancer
@ast
Promising novel therapies for the treatment of endometrial cancer
@en
prefLabel
Promising novel therapies for the treatment of endometrial cancer
@ast
Promising novel therapies for the treatment of endometrial cancer
@en
P2860
P1433
P1476
Promising novel therapies for the treatment of endometrial cancer
@en
P2093
Paola A Gehrig
Victoria L Bae-Jump
P2860
P304
P356
10.1016/J.YGYNO.2009.10.041
P407
P577
2009-11-10T00:00:00Z